| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19938737A1 Aminosalicylsäureamide Aminosalicylamides |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380775A1 Benzoic acid derivatives and their use as ppar receptor agonists |
| 02/22/2001 | CA2378712A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 02/22/2001 | CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | CA2377637A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/21/2001 | EP1077213A2 Inhibition of serotonin reuptake |
| 02/21/2001 | EP1076647A2 Antipsychotic indolyl derivatives |
| 02/21/2001 | EP1076646A1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 02/21/2001 | EP1076558A1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/21/2001 | CN1062270C Amino-acid derrivatives having benzothiophene ring, prep. thereof and use as fungus-killing agent |
| 02/21/2001 | CN1062264C Amino-acid indole or quinoline derivatives, prep. thereof and use as fungus-killing agent |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191161 Prolylendopeptidase inhibitors |
| 02/20/2001 | US6191160 Spiro-indolines as Y5 receptor antagonists |
| 02/20/2001 | US6190852 Coupler provides a desirably narrow spectrographic absorption curve. |
| 02/20/2001 | US6190850 Photographic element, compound, and process |
| 02/20/2001 | US6190641 Indocyanine dyes |
| 02/15/2001 | WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2000063296A3 Cyanine dyes and synthesis methods thereof |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | WO2000053313A3 Lanthanide catalysts for synthesis of compounds and combinatorial libraries |
| 02/15/2001 | WO1999042102A8 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 02/15/2001 | DE19937496A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents, e.g. for treating viral infections, tumors, inflammation or autoimmune disease |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/14/2001 | EP1075471A1 Indolyl derivatives as serotonergic agents |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP1075261A1 Mycobacterial inhibitors |
| 02/14/2001 | EP1021451A4 Asymmetric synthesis and catalysis with chiral heterocyclic compounds |
| 02/14/2001 | EP0708767B1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/14/2001 | CN1284064A 2,3-substituted indole compounds as cox-2 inhibitors |
| 02/14/2001 | CN1284058A Neuroprotective agents |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1284055A Derivatives of 2,2-dimethyl 3-(2-fluoro vinyl) cyclopropane carboxylic acid, their prepn process and use as pesticides |
| 02/14/2001 | CN1283615A New Process and intermediate |
| 02/14/2001 | CN1283455A Application of black fading hormone and black fading ligand in medicinal compsns for prevention and treatment of gastrointestional tract disease |
| 02/13/2001 | US6187931 Process for making fluorophthalimides |
| 02/13/2001 | US6187809 Beta-3 adrenaline receptor agonist drugs for the treatment of diabetes, obesity, and hyperlipemia; 2-(n-(2-(dibenzofuran-3-yloxy)ethyl)amino)-1-phenylethanol, for example |
| 02/13/2001 | US6187805 Indole and indoline derivatives as 5-HT6 selective ligands |
| 02/13/2001 | US6187776 Heterocyclic compounds and their use |
| 02/13/2001 | US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof |
| 02/13/2001 | US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000044717A3 Synthesis of oligoketides |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/07/2001 | EP1074542A1 Sulfonamide-containing indole compounds |
| 02/07/2001 | EP1073636A1 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073440A1 sPLA 2 INHIBITOR ESTER |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | CN1283190A Substituted benzene compounds, process for their preparation and herbicidal and defoliant composition containing them |
| 02/07/2001 | CN1283186A Indole derivatives as XA factor inhibitors |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
| 02/07/2001 | CN1282732A 'alpha'-hydroxy-'beta' amino acid ester and its preparation method |
| 02/07/2001 | CN1061653C Benzofuran compounds, process for their preparation and pharmaceutical compositions thereof |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184380 Process for preparing naphthyridones and intermediates |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/01/2001 | WO2001007435A2 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands |
| 02/01/2001 | WO2001007434A2 Indole derivatives and their use as 5ht2a ligands |
| 02/01/2001 | WO2001007409A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 02/01/2001 | WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds |
| 02/01/2001 | WO2001007403A1 Naphthyl-substituted sulfonamides |
| 02/01/2001 | WO2001007029A2 Substituted guanidines and the use thereof |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000058405A3 Squaraine dyes |
| 02/01/2001 | DE19934432A1 Indolderivate Indole derivatives |
| 02/01/2001 | CA2379859A1 Novel method for preparing benzoperhydroisoindole compounds |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | EP1071665A1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes |
| 01/31/2001 | EP1071664A1 Substituted 2-oxo-alkanoic acid- 2-(indol-3-yl)-ethyl] amides |
| 01/31/2001 | EP1071663A1 Process for preparing 4-substituted-1h-indole-3-glyoxamides |
| 01/31/2001 | EP1071661A1 Process for preparing 4-hydroxy indole, indazole and carbazole compounds |
| 01/31/2001 | EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/31/2001 | EP1071648A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 01/31/2001 | EP1071420A1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 01/31/2001 | CN1282320A Thermodynamically stable from of (R)-3-[[(4-fluorophenyl) sulphonyl] amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/31/2001 | CN1282242A Multicatalytic protease inhibitors for use as anti-tumor agents |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/30/2001 | US6180657 Melatonin derivatives for use in treating desynchronization disorders |
| 01/30/2001 | US6180644 Immunotherapeutic agents |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |